# Benefit of CFAE Ablation

> **NCT01711047** · NA · COMPLETED · sponsor: **Oxford University Hospitals NHS Trust** · enrollment: 120 (actual)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** Radiofrequency catheter Ablation
- **PROCEDURE:** Radiofrequency catheter ablation

## Key facts

- **NCT ID:** NCT01711047
- **Lead sponsor:** Oxford University Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2017-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01711047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01711047, "Benefit of CFAE Ablation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01711047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
